Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.105
+0.205 (5.26%)
Nov 19, 2026, 9:35 AM EST - Market open
Exagen Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Exagen stock has a consensus rating of "Strong Buy" and an average price target of $9.43. The average 1-year stock price forecast is 129.70% higher than the current stock price, while the lowest is $8.00 (+94.88%) and the highest is $12 (+192.33%).
Price Target: $9.43 (+129.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Exagen stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Maintains $11 → $9 | Buy | Maintains | $11 → $9 | +119.24% | Nov 11, 2026 |
| BTIG | BTIG | Buy Reiterates $9 | Buy | Reiterates | $9 | +119.24% | Nov 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $11 → $9 | Buy | Reiterates | $11 → $9 | +119.24% | Nov 10, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +192.33% | Nov 2, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +167.97% | Oct 13, 2026 |
Financial Forecast
Revenue This Year
73.74M
from 66.58M
Increased by 10.77%
Revenue Next Year
80.77M
from 73.74M
Increased by 9.52%
EPS This Year
-0.73
from -0.84
EPS Next Year
-0.50
from -0.73
EPS and Forward PE are based on non-GAAP adjusted numbers.